Cislieva 50mg

Cislieva 50mg Injection is classified as an alkylating agent within the medication category. This antineoplastic drug contains Cisplatin as its active component. It is utilized in the treatment of specific cancer types, including testicular, ovarian, bladder, lung, cervical, and head and neck epithelial tumors, either alone or in conjunction with radiotherapy.

If you have an allergy to Cisplatin or any of its components, it is essential to inform your doctor prior to commencing treatment with this medication. Additionally, notify your doctor if you experience hypersensitivity, myelosuppression (a decrease in blood cell count), or any hearing issues. Cislieva 50mg Injections should be avoided if you have recently received a live vaccine, such as the yellow fever vaccine. Therefore, please inform your doctor if you are planning to get vaccinated.

It is important to inform your doctor if you exhibit any signs of nerve damage (peripheral neuropathy) or if you have undergone radiotherapy to the head. This medication may lead to complications affecting your kidneys, liver, and blood. Consequently, your doctor may conduct regular blood tests to assess your blood, kidney, and liver functions. Both men and women are advised to use effective contraception during the course of this treatment and to continue its use for six months following the last dose. Furthermore, Cislieva 50mg Injection may lead to permanent fertility reduction in men, so it is recommended to seek advice regarding fertility issues from your healthcare provider.